Monte Rosa Therapeutics Inc.

GLUE
Date Form Type SEC Filings
Oct 30, 2024 SC 13D/A Profile Financial Statements
Oct 30, 2024 4 Profile Financial Statements
Oct 28, 2024 8-K Profile Financial Statements
Oct 28, 2024 144 Profile Financial Statements
Sep 24, 2024 SC 13D/A Profile Financial Statements
Sep 24, 2024 4 Profile Financial Statements
Sep 13, 2024 4 Profile Financial Statements
Aug 12, 2024 SC 13D/A Profile Financial Statements
Aug 8, 2024 10-Q Profile Financial Statements
Aug 8, 2024 8-K Profile Financial Statements
Jul 9, 2024 4 Profile Financial Statements
Jun 27, 2024 8-K Profile Financial Statements
Jun 13, 2024 4 Profile Financial Statements
May 30, 2024 8-K Profile Financial Statements
May 13, 2024 SC 13D/A Profile Financial Statements
May 9, 2024 8-K Profile Financial Statements
Apr 26, 2024 DEF 14A Profile Financial Statements
Apr 10, 2024 SC 13G/A Profile Financial Statements
Apr 10, 2024 144 Profile Financial Statements
Mar 14, 2024 8-K Profile Financial Statements
Mar 14, 2024 10-K Profile Financial Statements
Feb 14, 2024 SC 13G/A Profile Financial Statements
Jan 8, 2024 8-K Profile Financial Statements
Nov 9, 2023 8-K Profile Financial Statements
Nov 9, 2023 SC 13D/A Profile Financial Statements
Oct 26, 2023 8-K Profile Financial Statements
Oct 26, 2023 424B5 Profile Financial Statements
Oct 17, 2023 8-K Profile Financial Statements
Aug 18, 2023 3 Profile Financial Statements
Aug 15, 2023 144 Profile Financial Statements
Aug 10, 2023 10-Q Profile Financial Statements
Aug 10, 2023 8-K Profile Financial Statements
Jul 26, 2023 4 Profile Financial Statements
Jun 15, 2023 4 Profile Financial Statements
Mar 16, 2023 10-K Profile Financial Statements
Mar 29, 2022 10-K Profile Financial Statements